StonvexLoading…
StonvexStonvexStonvexCore line items from ENIC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | CLP 3.90T | CLP 4.26T | CLP 4.38T | CLP 2.83T |
Operating Income | CLP 373.06B | CLP 767.76B | CLP 912.36B | CLP 259.59B |
Net Income | CLP 191.04B | CLP 680.01B | CLP 1.31T | CLP 100.71B |
EPS (Diluted) | CLP 2.10 | CLP 9.16 | CLP 18.10 | CLP 1.23 |
Total Assets | CLP 12.72T | CLP 11.83T | CLP 11.87T | CLP 9.50T |
Total Liabilities | CLP 7.39T | CLP 7.07T | CLP 7.48T | CLP 6.15T |
Cash & Equivalents | CLP 383.40B | CLP 563.29B | CLP 875.21B | CLP 309.98B |
Free Cash Flow OCF − CapEx | CLP 846.90B | CLP 68.87B | CLP -170.91B | CLP -335.12B |
Shares Outstanding | Not available | Not available | Not available | Not available |